valproic acid has been researched along with Cytomegalic Inclusion Disease in 3 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ornaghi, S | 1 |
| Davis, JN | 1 |
| Gorres, KL | 1 |
| Miller, G | 1 |
| Paidas, MJ | 1 |
| van den Pol, AN | 1 |
| Iniesta, I | 1 |
| Shawcross, D | 1 |
| Auzinger, G | 1 |
3 other studies available for valproic acid and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Mood stabilizers inhibit cytomegalovirus infection.
Topics: Amides; Animals; Cell Line; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Disease Mo | 2016 |
Lamotrigine and the risk of fulminant hepatic failure.
Topics: Anticonvulsants; Cytomegalovirus Infections; Female; Humans; Lamotrigine; Liver Failure, Acute; Risk | 2007 |
Lamotrigine and the risk of fulminant hepatic failure.
Topics: Anticonvulsants; Cytomegalovirus Infections; Female; Humans; Lamotrigine; Liver Failure, Acute; Risk | 2008 |